


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.48%
+0.64%
-1.40%
-3.21%
-6.46%
BEAM
Beam Therapeutics In
$27.36
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
BEAM Price Performance
$22.02 (+24.25%)
$24.32 (+12.50%)
$20.95 (+30.60%)
$26.59 (+2.90%)
BEAM has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

BEAM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings decline YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
BEAM Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
BEAM Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is BEAM current stock price?
What are BEAM stock strengths?
What is BEAM Risk Level?
What is BEAM market cap and volume?
What is BEAM current Stock IQ?
Should I buy BEAM stock right now?
Is BEAM a Strong Buy right now?
What does a 'Strong Buy' rating mean for BEAM?
What does a 'Strong Sell' rating mean for BEAM?
What factors influence BEAM's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.48%
+0.64%
-1.40%
-3.21%
-6.46%
BEAM
Beam Therapeutics In
Current Price
$27.36
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

BEAM Price Performance
$22.02 (+24.25%)
$24.32 (+12.50%)
$20.95 (+30.60%)
$26.59 (+2.90%)
BEAM Analysts Opinion
BEAM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings decline YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
BEAM Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
BEAM Street Sentiment is extremely bullish and have positive views on the near-term outlook
BEAM has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
BEAM Stock IQ
BEAM Latest Analysis
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions. Issued on behalf of Avant Technologies Inc. News Commentary – Traditional pharmaceutical strategies are giving ground as breakthrough approvals for gene therapies and mRNA platforms target previously untreatable rare diseases with precision interventions[1]. Healthcare systems integrating AI diagnostic tools now match therapies to individual genetic profiles rather than treating broad populations with reactive symptom
Tue Dec 9, 2025
Beam Therapeutics: Strong Buy On BEAM-101 Progress And In Vivo LNP Shots On Goal.
Thu Dec 4, 2025
Wednesday Sector Leaders: Biotechnology Trucking Stocks. In trading on Wednesday biotechnology shares were relative leaders up on the day by about 4.3%. Leading the group were shares of Capricor Therapeutics up about 352.3% and shares of Beam Therapeutics up about 11.9% on the day.Also showing relative strength are trucking shar
Wed Dec 3, 2025
Evercore ISI Group Initiates Coverage of Beam Therapeutics (BEAM) with Outperform Recommendation. Fintel reports that on November 24 2025 Evercore ISI Group initiated coverage of Beam Therapeutics (NasdaqGS:BEAM) with a Outperform recommendation. Analyst Price Forecast Suggests 111.58% Upside
Tue Nov 25, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
BEAM Stock trends
BEAM Stock performance
BEAM Stock analysis
BEAM investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.